Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-28

Clinical Trial Update: Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated whether pentoxifylline can prevent chemotherapy-induced toxicities in breast cancer patients. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Mansoura University | Conditions: Breast Cancer Female, Breast Cancer Patients | Phase 2 | Status: COMPLETED